Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials.

Br J Cancer · 2012 · PMC3461163 · PMID 22910317

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

of marginal significanceP =0.07so close (0.05 < p ≤ 0.1)

A similar effect was also noted in patients with high CD31+ VD (using the median VD as a cutoff point), but the difference was of marginal significance ( Figure 3C ; P =0.07).

also in 464 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.